2,185
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Predictors for short-term successful weaning from continuous renal replacement therapy: a systematic review and meta-analysis

, , , , , , & show all
Article: 2176170 | Received 04 Jul 2022, Accepted 15 Dec 2022, Published online: 10 Feb 2023

References

  • Ronco C, Bellomo R, Kellum JA. Acute kidney injury. The Lancet. 2019;394(10212):1949–1964.
  • Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama. 2005;294(7):813–818.
  • Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73.
  • Andrikos E, Tseke P, Balafa O, et al. Epidemiology of acute renal failure in ICUs: a multi-center prospective study. Blood Purif. 2009;28(3):239–244.
  • Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a veterans administration study. Crit Care Med. 2009;37(9):2552–2558.
  • Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423.
  • Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Ame Soc Nephrol. 2001;12(suppl_1):S40–S43.
  • Maynar Moliner J, Honore PM, Sanchez-Izquierdo Riera JA, et al. Handling continuous renal replacement therapy-related adverse effects in intensive care unit patients: the dialytrauma concept. Blood Purif. 2012;34(2):177–185.
  • Honore PM, Jacobs R, Joannes-Boyau O, et al. Con: dialy- and continuous renal replacement (CRRT) trauma during renal replacement therapy: still under-recognized but on the way to better diagnostic understanding and prevention. Nephrol Dial Transplant. 2013;28(11):2723. (discussion 2727–2728).
  • van de Wetering J, Westendorp RG, van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol. 1996;7(1):145–150.
  • Roberts DM, Roberts JA, Roberts MS, et al. Investigators RRTS: variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med. 2012;40(5):1523–1528.
  • Roberts DM, Liu X, Roberts JA, et al. Investigators RRTS: a multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care. 2015;19(1):84.
  • Hoste EA, Blot SI, Lameire NH, et al. Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol. 2004;15(2):454–462.
  • Finkel KW, Podoll AS. Complications of continuous renal replacement therapy. Semin Dial. 2009;22(2):155–159.
  • Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122–133.
  • Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. Jama. 2016;315(20):2190–2199.
  • Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20.
  • Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627–1638.
  • Moher D, Liberati A, Tetzlaff J, et al. Group P: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.
  • Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009;37(9):2576–2582.
  • Frohlich S, Donnelly A, Solymos O, et al. Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy. J Crit Care. 2012;27(6)744:e741-745.
  • Heise D, Gries D, Moerer O, et al. Predicting restoration of kidney function during CRRT-free intervals. J Cardiothorac Surg. 2012;7:6.
  • Han SS, Bae E, Song SH, et al. NT-proBNP is predictive of the weaning from continuous renal replacement therapy. Tohoku J Exp Med. 2016;239(1):1–8.
  • Katayama S, Uchino S, Uji M, Ja et al. Factors predicting successful discontinuation of continuous renal replacement therapy. Anaesth Intensive Care. 2016;44(4):453–457.
  • Jeon J, Kim DH, Baeg SI, et al. Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Crit Care. 2018;22(1):255.
  • Kim CS, Bae EH, Ma SK, et al. A prospective observational study on the predictive value of serum cystatin C for successful weaning from continuous renal replacement therapy. Kidney Blood Press Res. 2018;43(3):872–881.
  • Raurich JM, Llompart-Pou JA, Novo MA, et al. Successful weaning from continuous renal replacement therapy. Associated risk factors. J Crit Care. 2018;45:144–148.
  • Chen X, Chen Z, Wei T, et al. The effect of serum neutrophil gelatinase-associated lipocalin on the discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury. Blood Purif. 2019;48(1):10–17.
  • Stads S, Kant KM, de Jong MFC, et al. Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study. BMC Nephrol. 2019;20(1):129.
  • Yoshida T, Matsuura R, Komaru Y, et al. Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation. Nephrology. 2019;24(3):287–293.
  • Zhang Z, Xu X, Ni H, et al. Serum cystatin C is associated with renal function recovery in critically ill patients undergoing continuous renal replacement therapy. Nephron Clin Pract. 2012;122(3-4):86–92.
  • Katulka RJ, Al Saadon A, Sebastianski M, et al. Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT). Crit Care. 2020;24(1):50.
  • Hsu CY, Ordonez JD, Chertow GM, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74(1):101–107.
  • James MT, Hemmelgarn BR, Wiebe N, et al. Alberta kidney disease N: glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet. 2010;376(9758):2096–2103.
  • Zeng X, McMahon GM, Brunelli SM, et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9(1):12–20.
  • Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81(9):819–825.
  • Bagshaw SM, George C, Bellomo R, et al. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12(2):R47.
  • Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. Jama. 2016;316(5):509–518.